Can BER be Used as a Biomarker for Cancer Diagnosis?
Alterations in BER components can serve as potential biomarkers for cancer diagnosis and prognosis. For instance, the expression levels of APE1 and Pol β have been studied in various cancers and correlated with patient outcomes. Monitoring these biomarkers can provide insights into the aggressiveness of the tumor and the likelihood of response to certain therapies.
